Emily Whitehead was just five when she battled an acute form of leukemia. Today, she is in remission thanks to a personalized cancer treatment. She was the first patient ever to receive CAR-T Cell therapy, which was developed at the Children’s Hospital of Pennsylvania. The therapy uses a patient’s own immune cells to fight off cancer cells. On Tuesday, a Federal Drug Administration Committee recommended the FDA approve the cancer therapy, which would give more children and young adults access to the groundbreaking treatment.